SCHEMBL29640600

SCHEMBL29640600

CC1(C)COc2cc(Br)ccc2C1=O

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
MALT1 Q9UDY8 1/20 0.38
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
S100A4 P26447 1/20 0.37
CYP19A1 P11511 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
BLM P54132 1/20 0.36
TDP2 O95551 1/20 0.36
AHR P35869 1/20 0.34
METAP1 P53582 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3456628 1.00 PBRM1 (0.40) PBRM1CA1CA2CA4CA7
SCHEMBL1977795 0.87 PBRM1 (0.43) PBRM1CA1CA2CA4CA7
SCHEMBL5344623 0.81 CA1 (0.41) PBRM1CA1CA2CA4CA7
SCHEMBL28827705 0.80 CA1 (0.38) PBRM1CA1CA2CA4CA7
SCHEMBL29920352 0.80 MAOB (0.41) CA1CA2CA7CA9MALT1
SCHEMBL1500180 0.80 MAOB (0.50) CA1CA2CA7CA9CYP19A1
SCHEMBL30251200 0.80 MAOB (0.50) CA1CA2CA7CA9CYP19A1
SCHEMBL29920575 0.80 MAOB (0.41) CA1CA2CA7CA9MALT1
SCHEMBL1500280 0.78 CYP19A1 (0.48) CA1CA2CA4CA7CA9
SCHEMBL31525604 0.78 CYP19A1 (0.48) CA1CA2CA4CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022188735-A1 HETEROCYCLIC COMPOUNDS AS HPK1 INHIBITORS GUANGDONG NEWOPP BIOPHARMACEUTICALS CO., LTD. (CN) 2022-09-15 WO disclosed
CN-114641477-A Novel compound having inhibitory activity against glucose ceramide synthase or pharmaceutically acceptable salt thereof, method for preparing same, and pharmaceutical composition comprising same 柳韩洋行 2022-06-17 CN disclosed